More than half of Australia's carbon dioxide emissions come from power stations. Storing these harmful gases underground can drastically reduce the rate of emission build-up in our atmosphere.

University of Queensalnd historian Dr Sarah Ferber is redefining contemporary bioethics to include a historical dimension. And she's planning a book exploring topics such as medicine and social morality, human experimentation, women and reproductive medicine, genetic research and euthanasia.

Cancer researchers in Melbourne and Innsbruck hunting for new options to treat cancer have flushed two promising new therapeutic targets from the genetic thickets of the p53-mediated apoptosis pathway: Puma and Noxa. [ + ]

The University of Newcastle and the Hunter Medical Research Institute have linked up with international life sciences supply company Amersham BioSciences to establish a sophisticated analytical laboratory for research into personalised medicine. [ + ]

Diabetes luminary Prof Paul Zimmet has been honoured by his peers, receiving the Kellion Award for his contribution to the field. [ + ]

A nano-structured silicon device containing slow-release radiotherapy has successfully halted tumours in an animal study. [ + ]

Research into a promising new anti-diabetes compound derived from tree bark will receive a major funding boost under a heads of agreement deal brokered in Melbourne this week. [ + ]

Small molecule drug company Progen Industries (ASX:PGL, Nasdaq:PGLAF) has doubled its cash reserves in a share placement aimed to help the Brisbane biotech expand its product pipeline. [ + ]

It has been a week for collaborations at the Melbourne-based polyvalent nanotechnology development company, Starpharma (ASX:SPL). [ + ]

A new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise. [ + ]

Brisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States. [ + ]

Carrying on a strong tradition of world class immunology research in Australia, the A$300,000 Prime Minister's Prize for Science has been awarded to Emeritus Professor Jacques Miller AC of the Walter and Eliza Hall Institute of Medical Research in Melbourne.

Bioactive compound development company Novogen (ASX:NRT) has appointed the chief of biotech TGR BioSsciences to its board of directors. [ + ]

Pathology giant Gribbles (ASX:GGL) has announced a new subsidiary dedicated to biotechnology, with its first project being the development of a pre-natal screening test to detect genetic and chromosomal abnormalities. [ + ]

The Victorian state government's Department of Innovation, Industry and Regional Development (DIIRD) has put up for tender the review of its Biotechnology Strategic Development Plan. [ + ]